108 related articles for article (PubMed ID: 8792921)
1. Measurement of serum levels of eosinophil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietaria pollen (treated and untreated with specific immunotherapy).
D'Amato G; Liccardi G; Russo M; Saggese M; D'Amato M
Allergy; 1996 Apr; 51(4):245-50. PubMed ID: 8792921
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of soluble CD23 in patients with asthma or rhinitis monosensitive to Parietaria. Its relation to total serum IgE levels and eosinophil cationic protein during and out of the pollen season.
Di Lorenzo G; Drago A; Pellitteri ME; Candore G; Colombo A; Potestio M; Di Salvo A; Mansueto S; Caruso C
Allergy Asthma Proc; 1999; 20(2):119-25. PubMed ID: 10209690
[TBL] [Abstract][Full Text] [Related]
3. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients.
Rak S; Löwhagen O; Venge P
J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):470-80. PubMed ID: 3170995
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of eosinophil cationic protein and eosinophil protein x in pollen atopic patients with stable asthma and its relation with bronchial hyperresponsiveness.
Chivato T; Martínez D; Blasco R; Melgarejo M; Gómez de Terreros FJ; Laguna R
Allergol Immunopathol (Madr); 1996; 24(6):243-7. PubMed ID: 9010559
[TBL] [Abstract][Full Text] [Related]
6. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma.
Vatrella A; Ponticiello A; Parrella R; Romano L; Zofra S; DiLeva A; Bariffi F
Allergy; 1996 Aug; 51(8):547-55. PubMed ID: 8874658
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of seasonal variability in bronchial hyper-responsiveness and sputum cell counts in non-asthmatic subjects with rhinitis and effect of specific immunotherapy.
Polosa R; Li Gotti F; Mangano G; Mastruzzo C; Pistorio MP; Crimi N
Clin Exp Allergy; 2003 Jul; 33(7):873-81. PubMed ID: 12859441
[TBL] [Abstract][Full Text] [Related]
8. Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis.
Winther L; Moseholm L; Reimert CM; Stahl Skov P; Kaergaard Poulsen L
Allergy; 1999 May; 54(5):436-45. PubMed ID: 10380774
[TBL] [Abstract][Full Text] [Related]
9. The effect of immunotherapy on the serum levels of eosinophil cationic protein in seasonal allergic rhinitis.
Ohashi Y; Nakai Y; Kakinoki Y; Ohno Y; Okamoto H; Sakamoto H; Kato A; Tanaka A
Clin Otolaryngol Allied Sci; 1997 Apr; 22(2):100-5. PubMed ID: 9160918
[TBL] [Abstract][Full Text] [Related]
10. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
Orhan F; Sekerel BE; Adalioglu G; Pinar M; Tuncer A
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
[TBL] [Abstract][Full Text] [Related]
11. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
Ferdousi HA; Dreborg S
Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
[TBL] [Abstract][Full Text] [Related]
12. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
[TBL] [Abstract][Full Text] [Related]
13. [The immunological parameters and risk factors for pollen-induced allergic rhinitis and asthma].
Staikūniene J; Sakalauskas R
Medicina (Kaunas); 2003; 39(3):244-53. PubMed ID: 12695637
[TBL] [Abstract][Full Text] [Related]
14. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
15. Effect of immunotherapy on eosinophil activation in pollen sensitive children.
Pronk-Admiraal CJ; Schilte PP; Bartels PC
Clin Lab; 2001; 47(5-6):231-8. PubMed ID: 11405601
[TBL] [Abstract][Full Text] [Related]
16. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
[TBL] [Abstract][Full Text] [Related]
17. Effects of immunotherapy on the inflammation in pollen asthma.
Rak S
Allergy; 1993; 48(17 Suppl):125-8; discussion 143-4. PubMed ID: 8109703
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of bronchial eosinophil activity in seasonal allergic rhinitis by induced plasma exudation combined with induced sputum.
Greiff L; Andersson M; Svensson C; Linden M; Wollmer P; Persson CG
Thorax; 1999 Jan; 54(1):33-6. PubMed ID: 10343628
[TBL] [Abstract][Full Text] [Related]
19. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma.
Rak S; Heinrich C; Jacobsen L; Scheynius A; Venge P
J Allergy Clin Immunol; 2001 Dec; 108(6):921-8. PubMed ID: 11742269
[TBL] [Abstract][Full Text] [Related]
20. [The influence of a three-year preseasonal specific immunotherapy on selected parameters of allergic inflammation in pollinosis patients].
Fal AM; Gietkiewicz K; Obojski A; Medrala W; Małolepszy J
Pneumonol Alergol Pol; 2002; 70(1-2):78-86. PubMed ID: 12148181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
